The weekly litigation news digest is live. Subscribe now

IP Verse

Injectable Antibiotic Formulations And Their Methods Of Use - EP2874624

The patent EP2874624 was granted to Bayer on Oct 2, 2019. The application was filed on Jul 16, 2013 under application number EP13819728A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2874624

BAYER
Application Number
EP13819728A
Filing Date
Jul 16, 2013
Status
Opposition Rejected
Jul 22, 2022
Publication Date
Oct 2, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
OMNIPHARM DEVELOPMENTSMay 21, 2020CARPMAELS & RANSFORDADMISSIBLE
EUROVET ANIMAL HEALTHMay 20, 2020ALGEMEEN OCTROOI EN MERKENBUREAUADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTCN1517090
INTERNATIONAL-SEARCH-REPORTUS4446144
OPPOSITIONCA1237672
OPPOSITIONCN101822637
OPPOSITIONCN1517090
OPPOSITIONEP0941095
OPPOSITIONGB2087236
OPPOSITIONUS2004022815
OPPOSITIONUS2011223208
OPPOSITIONUS4446144
OPPOSITIONUS4594246
OPPOSITIONUS6911441
OPPOSITIONWO2004014339
OPPOSITIONWO2011128783
OTHERCA1237672
OTHERCN101822637
OTHERCN1517090
SEARCHGB2087236
SEARCHUS4594246

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents